InsidersTradesSigma
제이투케이바이오 Stock: price and management transactions · South Korea · DART (FSS)
Follow the 제이투케이바이오 stock price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are listed on KR KR, under the oversight of DART (FSS). Operating in the Chemicals sector, 제이투케이바이오 has recorded 2 insider filings. Market capitalisation: €53.3bn. The latest transaction was filed on 12 May 2026 (Purchase). Among the most active insiders: 김석종. All data is accessible without an account.
2
Insider Decl.
n/a
Thresholds
€21,390
1 ops.
Buy Volume
n/a
1 ops.
Sell Volume
23Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 8,661 of 27,906 companies
61.0
score / 100
Value53
Quality69
FCF yld1.7%
Earn yld4.8%
EV/EBITDA12.3x
ROE12%
Gross mgn39%
Net mgn8.1%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 12 May 2026
About 제이투케이바이오
J2K Bio is a company operating in the chemical and materials sector, listed on the XKRX. It specializes in the development of biotechnology solutions.